Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
ACCESSWIRE
Announces Regulatory and Compliance Advisory Board
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ( Pharma-Bio Serv or the Company ) (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues for the three and six months ended April 30, 2021 were $5,042,000 and $9,530,000, respectively, a decrease of approximately $606,000 and $731,000, respectively, when compared to the same periods last year.
Net income for the three and six months ended April 30, 2021 was approximately $240,000 and $508,000, a decrease of approximately $448,000 and $706,000 when compared to the same periods last year, respectively. The decrease in net income is mainly attributable to the completion of projects
Puerto-rico
United-states
America
Pedroj-lasanta
Victor-sanchez
Exchange-commission
Company-contact
Pharma-bio-serv-inc
Announces-regulatory
Compliance-advisory
Pharma-bio-serv
Pharma-bio-serv